Advanced Search
Contact | Corporate | Help

Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors

Sponsors:
  • Accelerated Community Oncology Research Network
  • GlaxoSmithKline
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Metastatic Solid Tumor
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Topotecan
  • Drug: Erlotinib
Enrollment:
29

Additional information about NCT00611468.


SourceSolution © 2008-2012